CBX3 and hepatocellular carcinoma: Here, we confirmed that CBX3 depletion blocked the effects of miR-29a-3p inhibitor on cell proliferation, apoptosis, migration, and invasion in SEVO-treated HCC cells (Figure 7A-G).